Overview

Clinical Trials to Assess the Efficacy and Safety of HLIM

Status:
Unknown status
Trial end date:
2019-10-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to assess the efficacy and safety of HLIM
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
SamA Pharmaceutical Co., Ltd
Criteria
Inclusion Criteria:

- Age between 2 and 75

- Weight more than 11.5 kg

Exclusion Criteria:

- Has a history of hypersensitivity to IP ingredients

- Hypertension or Diabetes

- Smoking more than 20 pack-years